UNSPSC 51282402: Pivmecillinam or amdinocillin pivoxil

This classification denotes a penicillin antibiotic with the molecular formula C21H33N3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1WAM1OQ30B, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((hexahydro-1h-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (2s-(2alpha,5alpha,6beta))- but generally known as amdinocillin pivoxil, which bears US NIH Compound Identifier 36272.

UNSPSC 51282402 Pivmecillinam or amdinocillin pivoxil is a Commodity code that in recent state and local procurement activity covers pharmaceutical products and medical supplies—including naloxone, OTC medications, and generic multi-source drugs—sourced through cooperative purchasing vehicles and direct government procurements. State and local issuing bodies soliciting under this code include county health departments, state health and human services agencies, municipal fire departments, and multistate cooperative purchasing alliances. The Seminole County, Florida naloxone procurement (IFB60459723LAS, due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually for community health initiatives; the City of Tampa fire rescue procurement (26P00145, due March 13, 2026) covered 169 line items of medical and first aid supplies, including respiratory equipment, cardiac monitoring electrodes, and consumables, with an estimated contract value of $700,000 and a sheltered-market set-aside for certified Small Local Business Enterprises. The Texas Health and Human Services Commission's RFI (HHS0017013, posted April 3, 2026) sought vendor capabilities for direct-to-manufacturer prescription fulfillment programs operating outside traditional pharmacy benefit manager arrangements.

Recent activity clusters in Florida, Texas, and the upper Midwest, with the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) administering a major RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products across Minnesota, Oregon, and participating jurisdictions. MMCAP requires vendors to supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co.—and mandates certification compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act, with contract terms of two years for new vendors effective July 1, 2026. The code shows modest but geographically dispersed activity spanning cooperative purchasing, municipal and county procurement, and state health agency initiatives, with emphasis on competitive bidding, wholesale channel partnerships, and regulatory compliance for medication and medical supply distribution.